Novel insights into G protein and G protein-coupled receptor signaling in cancer

Current Opinion in Cell Biology

Volumn 27, Issue 1, 2014, Pages 126-135

  O'Hayre, Morgan ^a   Degese, Maria S ^a   Gutkind, J Silvio ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TARGET OF RAPAMYCIN KINASE; TUMOR SUPPRESSOR PROTEIN; VIRUS PROTEIN;

ANGIOGENESIS; CANCER CELL; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; GENE MUTATION; HUMAN; IMMUNE EVASION; IMMUNOCOMPETENT CELL; INFLAMMATION; INTRACELLULAR SIGNALING; METASTASIS; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; CYTOSKELETON; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SECOND MESSENGER; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETON; GTP-BINDING PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR CROSS-TALK; RECEPTORS, G-PROTEIN-COUPLED; RHO GTP-BINDING PROTEINS; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; VIRAL PROTEINS;

EID: 84893437204     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2014.01.005     Document Type: Review

References (91)

1. Rosenbaum D.M., Rasmussen S.G., Kobilka B.K. The structure and function of G-protein-coupled receptors. Nature 2009, 459:356-363.
2. Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002, 3:639-650.
3. Nabhan J.F., Pan H., Lu Q. Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the beta2-adrenergic receptor. EMBO Rep 2010, 11:605-611.
4. Dorsam R.T., Gutkind J.S. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007, 7:79-94.
5. Magalhaes A.C., Dunn H., Ferguson S.S. Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins. Br J Pharmacol 2012, 165:1717-1736.
6. Lappano R., Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 2011, 10:47-60.
7. Zwick E., Bange J., Ullrich A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 2001, 8:161-173.
8. Ui M., Katada T. Bacterial toxins as probe for receptor-Gi coupling. Adv Second Messenger Phosphoprotein Res 1990, 24:63-69.
9. Chambard J.C., Paris S., Pouyssegur G.L.A.J. Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin. Nature 1987, 326:800-803.
10. Pouyssegur J., Chambard J.C., Magnaldo G.L.A., Seuwen K.I. Transmembrane signalling pathways initiating cell growth in fibroblasts. Philos Trans R Soc Lond B Biol Sci 1988, 320:427-436.
11. van Corven E.J., Groenink A., Jalink K., Eichholtz T., Moolenaar W.H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 1989, 59:45-54.
12. Moolenaar W.H. G-protein-coupled receptors, phosphoinositide hydrolysis, and cell proliferation. Cell Growth Differ 1991, 2:359-364.
13. van Biesen T., Luttrell L.M., Hawes B.E., Lefkowitz R.J. Mitogenic signaling via G protein-coupled receptors. Endocr Rev 1996, 17:698-714.
14. Rozengurt E. Early signals in the mitogenic response. Science 1986, 234:161-166.
15. Taussig R., Iniguez-Lluhi J.A., Gilman A.G. Inhibition of adenylyl cyclase by Gi alpha. Science 1993, 261:218-221.
16. Hubbard K.B., Hepler J.R. Cell signalling diversity of the Gqalpha family of heterotrimeric G proteins. Cell Signal 2006, 18:135-150.
17. Sassone-Corsi P. The cyclic AMP pathway. Cold Spring Harb Perspect Biol 2012, 4.
18. Howe A.K. Cross-talk between calcium and protein kinase A in the regulation of cell migration. Curr Opin Cell Biol 2011, 23:554-561.
19. Prevarskaya N., Skryma R., Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer 2011, 11:609-618.
20. Griner E.M., Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007, 7:281-294.
21. Julius D., Nathans J. Signaling by sensory receptors. Cold Spring Harb Perspect Biol 2012, 4:a005991.
22. Newton A.C. Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 2010, 298:E395-E402.
23. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 1998, 273:1839-1842.
24. Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J.S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995, 81:1137-1146.
25. Rosenfeldt H., Vazquez-Prado J., Gutkind J.S. P-REX2, a novel PI-3-kinase sensitive Rac exchange factor. FEBS Lett 2004, 572:167-171.
26. Welch H.C., Coadwell W.J., Ellson C.D., Ferguson G.J., Andrews S.R., Erdjument-Bromage H., Tempst P., Hawkins P.T., Stephens L.R. P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 2002, 108:809-821.
27. Lutz S., Shankaranarayanan A., Coco C., Ridilla M., Nance M.R., Vettel C., Baltus D., Evelyn C.R., Neubig R.R., Wieland T., et al. Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs. Science 2007, 318:1923-1927.
28. Mikelis C.M., Palmby T.R., Simaan M., Li W., Szabo R., Lyons R., Martin D., Yagi H., Fukuhara S., Chikumi H., et al. PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation. J Biol Chem 2013, 288:12232-12243.
29. Laplante M., Sabatini D.M. mTOR signalling. Cold Spring Harb Perspect Biol 2012, 4.
30. Hemmings B.A., Restuccia D.F. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol 2012, 4:a011189.
31. Lopez-Ilasaca M., Crespo P., Pellici P.G., Gutkind J.S., Wetzker R. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 1997, 275:394-397.
32. Costa C., Martin-Conte E.L., Hirsch E. Phosphoinositide 3-kinase p110gamma in immunity. IUBMB Life 2011, 63:707-713.
33. Engelman J.A., Luo J., Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006, 7:606-619.
34. Ciraolo E., Iezzi M., Marone R., Marengo S., Curcio C., Costa C., Azzolino O., Gonella C., Rubinetto C., Wu H., et al. Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development. Sci Signal 2008, 1:ra3.
35. Yu F.X., Zhao B., Panupinthu N., Jewell J.L., Lian I., Wang L.H., Zhao J., Yuan H., Tumaneng K., Li H., et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012, 150:780-791.
36. Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010, 19:491-505.
37. Ramos A., Camargo F.D. The Hippo signaling pathway and stem cell biology. Trends Cell Biol 2012, 22:339-346.
38. Zhao B., Li L., Lei Q., Guan K.L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 2010, 24:862-874.
39. Sudol M., Bork P., Einbond A., Kastury K., Druck T., Negrini M., Huebner K., Lehman D. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J Biol Chem 1995, 270:14733-14741.
40. Yu F.X., Guan K.L. The Hippo pathway: regulators and regulations. Genes Dev 2013, 27:355-371.
41. Vaque J.P., Dorsam R.T., Feng X., Iglesias-Bartolome R., Forsthoefel D.J., Chen Q., Debant A., Seeger M.A., Ksander B.R., Teramoto H., et al. A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors. Mol Cell 2013, 49:94-108.
42. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308:512-517.
43. Luttrell L.M., Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002, 115:455-465.
44. Luttrell L.M., Gesty-Palmer D. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 2010, 62:305-330.
45. Rajagopal S., Rajagopal K., Lefkowitz R.J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 2010, 9:373-386.
46. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402:884-888.
47. Natarajan K., Berk B.C. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. Methods Mol Biol 2006, 332:51-77.
48. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
49. Martin D., Gutkind J.S. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene 2008, 27(Suppl 2):S31-S42.
50. Montaner S., Kufareva I., Abagyan R., Gutkind J.S. Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. Annu Rev Pharmacol Toxicol 2013, 53:331-354.
51. Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M.C., Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [see comments]. Nature 1997, 385:347-350.
52. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2:563-572.
53. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
54. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004, 4:540-550.
55. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374.
56. Liang Z., Wu T., Lou H., Yu X., Taichman R.S., Lau S.K., Nie S., Umbreit J., Shim H. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004, 64:4302-4308.
57. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003, 425:307-311.
58. Burger J.A., Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
59. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003, 111:187-196.
60. Sosa M.S., Lopez-Haber C., Yang C., Wang H., Lemmon M.A., Busillo J.M., Luo J., Benovic J.L., Klein-Szanto A., Yagi H., et al. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell 2010, 40:877-892.
61. Yagi H., Tan W., Dillenburg-Pilla P., Armando S., Amornphimoltham P., Simaan M., Weigert R., Molinolo A.A., Bouvier M., Gutkind J.S. A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells. Sci Signal 2011, 4:ra60.
62. Zlotnik A., Burkhardt A.M., Homey B. Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol 2011, 11:597-606.
63. O'Hayre M., Salanga C.L., Handel T.M., Allen S.J. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 2008, 409:635-649.
64. Tang X., Jin R., Qu G., Wang X., Li Z., Yuan Z., Zhao C., Siwko S., Shi T., Wang P., et al. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Galphaq-p63RhoGEF-Rho GTPase pathway. Cancer Res 2013, 73:6206-6218.
65. Moore B.B., Keane M.P., Addison C.L., Arenberg D.A., Strieter R.M. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J Investig Med 1998, 46:113-120.
66. Richard D.E., Vouret-Craviari V., Pouyssegur J. Angiogenesis and G-protein-coupled receptors: signals that bridge the gap. Oncogene 2001, 20:1556-1562.
67. Wang D., Dubois R.N. Prostaglandins and cancer. Gut 2006, 55:115-122.
68. Iniguez M.A., Rodriguez A., Volpert O.V., Fresno M., Redondo J.M. Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends Mol Med 2003, 9:73-78.
69. Brown J.R., DuBois R.N. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 2005, 23:2840-2855.
70. Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001, 1:11-21.
71. Hull M.A., Ko S.C., Hawcroft G. Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?. Mol Cancer Ther 2004, 10:1-1039.
72. Hansen-Petrik M.B., McEntee M.F., Jull B., Shi H., Zemel M.B., Whelan J. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. Cancer Res 2002, 62:403-408.
73. Sonoshita M., Takaku K., Sasaki N., Sugimoto Y., Ushikubi F., Narumiya S., Oshima M., Taketo M.M. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat Med 2001, 7:1048-1051.
74. Castellone M.D., Teramoto H., Williams B.O., Druey K.M., Gutkind J.S. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005, 310:1504-1510.
75. Shao J., Jung C., Liu C., Sheng H. Prostaglandin E2 stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem 2005, 280:26565-26572.
76. Rollins B.J. Inflammatory chemokines in cancer growth and progression. Eur J Cancer 2006, 42:760-767.
77. O'Hayre M., Vazquez-Prado J., Kufareva I., Stawiski E.W., Handel T.M., Seshagiri S., Gutkind J.S. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 2013, 13:412-424.
78. Landis C.A., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989, 340:692-696.
79. Weinstein L.S., Shenker A., Gejman P.V., Merino M.J., Friedman E., Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome [see comments]. N Engl J Med 1991, 325:1688-1695.
80. Drews R.T., Gravel R.A., Collu R. Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis. Mol Cell Endocrinol 1992, 87:125-129.
81. Wilson C.H., McIntyre R.E., Arends M.J., Adams D.J. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene 2010, 29:4567-4575.
82. Kan Z., Jaiswal B.S., Stinson J., Janakiraman V., Bhatt D., Stern H.M., Yue P., Haverty P.M., Bourgon R., Zheng J., et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010, 466:869-873.
83. Epstein E.H. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008, 8:743-754.
84. Rubin L.L., de Sauvage F.J. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 2006, 5:1026-1033.
85. Lum L., Beachy P.A. The Hedgehog response network: sensors, switches, and routers. Science 2004, 304:1755-1759.
86. Xie J., Murone M., Luoh S.M., Ryan A., Gu Q., Zhang C., Bonifas J.M., Lam C.W., Hynes M., Goddard A., et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998, 391:90-92.
87. Paavola K.J., Hall R.A. Adhesion G protein-coupled receptors: signaling, pharmacology, and mechanisms of activation. Mol Pharmacol 2012, 82:777-783.
88. Mitra D., Luo X., Morgan A., Wang J., Hoang M.P., Lo J., Guerrero C.R., Lennerz J.K., Mihm M.C., Wargo J.A., et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature 2012, 491:449-453.
89. Velasco G., Sanchez C., Guzman M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 2012, 12:436-444.
90. Green J.A., Suzuki K., Cho B., Willison L.D., Palmer D., Allen C.D., Schmidt T.H., Xu Y., Proia R.L., Coughlin S.R., et al. The sphingosine 1-phosphate receptor S1P(2) maintains the homeostasis of germinal center B cells and promotes niche confinement. Nat Immunol 2011, 12:672-680.
91. Lee J.H., Miele M.E., Hicks D.J., Phillips K.K., Trent J.M., Weissman B.E., Welch D.R. KiSS-1: a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996, 88:1731-1737.